# A Phase II Trial Evaluating Upfront Stereotactic Body Radiotherapy in Stage III Advanced Non-small Cell Lung Cancer

> **NCT07565987** · NA · RECRUITING · sponsor: **All India Institute of Medical Sciences** · enrollment: 20 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **RADIATION:** SBRT in stage III NSCLC

## Key facts

- **NCT ID:** NCT07565987
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-01
- **Primary completion:** 2025-01-30
- **Final completion:** 2027-01-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07565987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07565987, "A Phase II Trial Evaluating Upfront Stereotactic Body Radiotherapy in Stage III Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07565987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*